Researchers at the recent San Antonio Breast Cancer Symposium presented promising data for treating people with metastatic breast cancer, Sylvia Adams, MD, director of the Breast Cancer Center at NYU Langone Health’s Perlmutter Cancer Center, tells MedPage Today. These clinical trial results include treatments for triple-negative, estrogen receptor–positive, and HER2-positive breast cancers.
“Metastatic breast cancer is still a fatal disease,” says Dr. Adams, also a professor in the Department of Medicine at NYU Grossman School of Medicine. “However, in most subtypes now there’s been dramatic progress in terms of survival improvements after new therapies have come to clinical trials and to the market.”
Read and watch more on MedPage Today.